It has been reported that the protein level of PRMT1 is upregulated in hepatocellular carcinoma (HCC) to promote tumor progression, and its high level correlates with poor clinical outcomes in HCC patients13,14. The gene discussed is PRMT1; the disease is hepatocellular carcinoma.